This Million Targets Drug: A $7M Bet on a CNS Breakthrough
A focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
In a dual income household, Zero Based Budgeting In A Dual Income Household coordinates two paychecks toward shared priorities and debt reduction.
20,391 articlesA focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
The Invesco S&P 500 Momentum ETF (SPMO) is again outperforming SPY on a trailing basis while showing resilience durin...
AI is nearing a dramatic turning point. Wedbush predicts a 2026 inflection, and this article explains what that means...
Henry Hub natural gas vaulted to $7.72 in January before tumbling to $3.62 in February, forcing traders to pick sides...
Federal investigators say UCLA's David Geffen School of Medicine used race in admissions in ways that violated civil ...
BridgeBio's Q1 2026 earnings narrative is more than quarterly numbers—it's a roadmap for the year ahead. This guide e...
Oklo stock climbing higher this week is driven by regulatory progress on its Aurora reactor and broader interest in a...
A clash between the fast-food giant’s value-menu push and a traffic-led steakhouse model drives a new look at restaur...
Investors eye the Fennec Q1 2026 call to gauge milestones, cash runway, and potential catalysts. This guide breaks do...
Investors often wrestle with where to place bets: a volatile crypto project or a disruptive nuclear-tech equity. This...
A quiet, disciplined bet on the entire U.S. equity landscape. Pennington Partners increasing its stake in VTHR highli...
AI megacaps have powered the bulk of S&P 500 gains over the past two years. When AI-related stocks are stripped out, ...